Friday's Midday Movers: Micron Technology, Winnebago, Cleveland BioLabs And More

Following Thursday’s hot IPO day, Friday had many notable movers:

Winners

Cleveland BioLabs Inc CBLI - Moved up 7 percent as it continues its rally after a securities purchase agreement with David Davidovich for ~6.46 million unregistered common shares priced at $3.87 per share.

Neuralstem Inc CUR - Was up 6.4 percent after the biopharmaceutical company released preclinical data on its modified HK532-IGF-1 stem cells in Alzheimer’s disease; Researchers found the results to be encouraging and are recommending further studies.

Winnebago Industries Inc WGO - Continues up 6.29 percent after beating third quarter earnings estimates; The company also announced Brad Herzog as their newest contributor.

Magnum Hunter Resources Corporation MHR - Continues its rally on Friday, up 5.7 percent after the oil and gas producer pays debts (~ $300-$400 million of its selling stake in a gathering system), and resumes its drilling operations.

Restoration Hardware Holdings Inc RH - Up 5 percent after the company was upgraded by analysts at BB&T Capital. Analysts rated the luxury home furnishing retailer at a Buy, up from previous Hold and set a price target of $120.

Losers

Celladon Corporation CLDN - Declined 42 percent after the clinical biotech company reported it would append any further developments and research and considers liquidation if the company does not find a merging partner or acquirer.

Real Good Solar Inc RGSE - Was down 22 percent after the company entered into a securities purchase agreement along many institutional and accredited investors; It also announced to sell $800,000 of units to additional investors at $3.65 per unit, down from Thursday’s close of $4.36.

Micron Technology Inc MU - Was down 19 percent after the company reported disappointing third quarter earnings alongside guidance; Micron missed earnings by $0.02, at $0.54 per share and reported sales of $3.85 billion, down from previous $3.98 billion and analyst expectations of $3.90 billion.

Zoetis Inc ZTS - Was down 10.50 percent after receiving a buyout bid from Valeant Pharmaceuticals International Inc VRX on Thursday.